poisar

Stocks · News reference

Upexi Q4 EPS $(0.21) Misses $(0.12) Estimate, Sales $3.149M Miss $7.572M Estimate

BenzingaBenzinga Newsdesk

Upexi (NASDAQ:UPXI) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent. This is a 16 percent increase over losses of $(0.25) per share from the same

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Insights

    Full Transcript: Upexi Q4 2026 Earnings Call

    Upexi (NASDAQ:UPXI) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

  2. SEC EDGARSEC EDGAR

    8-K filing — UPEXI, INC. (UPXI)

    Filed: 2026-09-17 AccNo: 0001477932-26-005669 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

  3. BenzingaBenzinga Insights

    Earnings Scheduled For September 17, 2026

    Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10